• Rho Named a Best CRO with Life Sciences Award from the Triangle Business Journal

    May 28, 2015, 00:00 AM by Michael Croft
    CHAPEL HILL, NC - May 28, 2015 - Rho Named a Best CRO with Life Sciences Award
    from the Triangle Business Journal
     Chapel Hill, NC  ̶  May 27, 2015  ̶  Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, recently announced that the company was recognized as one of the Best CROs by the Triangle Business Journal, a multimedia source for local business news, research and events in the Raleigh, Durham, Chapel Hill region of North Carolina, where Rho is headquartered
    Full story
  • Juno Therapeutics Partners with Editas Medicine on CRISPR-Engineered Cancer Immunotherapies

    May 27, 2015, 12:10 PM by Michael Croft
    Bio-IT World | Biotech funding must be hot indeed when an 18-month-old immunotherapy company can pledge hundreds of millions to an 18-month-old genome editing company, but there's plenty of promise combining CAR T therapy with CRISPR technology — as rivals Novartis and Intellia Therapeutics made clear when they forged their own partnership this January.
    Full story
  • QIAGEN Launches NGS Clinical Insights Platform

    May 27, 2015, 09:00 AM by Michael Croft
    Bio-IT World News Brief | Yesterday afternoon QIAGEN announced the commercial launch of QIAGEN Clinical Insight (QCI), a bioinformatics content and software platform for clinical testing labs to interpret and report on genomic variants identified in next-generation sequencing (NGS). The first two supported applications for the bioinformatics platform are in oncology, for somatic and hereditary cancer testing. 
    Full story
  • New CLARITY Challenge Open to Entries, to Tackle Undiagnosed Diseases

    May 21, 2015, 10:00 AM by Michael Croft
    Clinical Informatics News | Boston Children’s Hospital is launching CLARITY Undiagnosed, a $25,000 competition to identify molecular diagnoses for five families with as-yet undiagnosed conditions. The Challenge kicks off in conjunction with a documentary film tracing the journeys of the patients and—possibly—the teams. Teams have until June 11 to register
    Full story
  • Genome in a Bottle Uncapped

    May 21, 2015, 09:40 AM by Michael Croft
    Bio-IT World | As the Genome in a Bottle Consortium and the National Institute of Standards and Technology announce the first reference DNA samples as trusted standards for genomic sequencing, the FDA weighs a regulatory role for the new reference material.
    Full story
  • Biodesix Launches GeneStrat Targeted Liquid Biopsy Mutation Test For Patients With Advanced Lung Cancer

    May 21, 2015, 00:00 AM by Michael Croft
    BOULDER, CO, UNITED STATES - May 21, 2015 - BOULDER, Colo.—May 21, 2015—Biodesix, Inc. today announced the launch of GeneStrat™, a targeted liquid biopsy mutation test for genotyping tumors of patients with advanced non-small cell lung cancer (NSCLC)
    Full story
  • KCR Accomplishes ISO 9001:2008 Certification for All Company Services

    May 21, 2015, 00:00 AM by Michael Croft
    BERLIN, GERMANY - May 21, 2015 - KCR, a Contract Research Organization (CRO), operating in 19 countries in Europe as well as the U.S., has recently validated the quality and accuracy of its operations receiving ISO 9001:2008 Certification for all its services
    Full story
  • Rho Showcases Clinical Services Expertise at OCT East Coast

    May 21, 2015, 00:00 AM by Michael Croft
    CHAPEL HILL, NC - May 21, 2015 -   Rho Showcases Clinical Services Expertise at OCT East Coast WHAT:           Rho, a full-service contract research organization (CRO), will highlight its continued success in drug development strategies and services during the 6th annual Outsourcing in Clinical Trials (OCT) East Coast conference, being held May 27-28 in King of Prussia, Pennsylvania
    Full story
  • Schizophrenia Genomics Study Looks for Somatic Mosaicism in Brain Cells

    May 20, 2015, 12:00 PM by Michael Croft
    Bio-IT World | The Lieber Institute for Brain Development (LIBD) announced a 5-year, $10.5 million grant from the National Institutes of Health (NIH) to support a first-of-its-kind multi-site, interdisciplinary project to research potentially non-inherited genetic causes of schizophrenia. By identifying the root biological origins now, more precise and effective therapies can be developed later.
    Full story
  • Celgene to Use Cypher Genomics’ Data Analytics in Drug Development

    May 20, 2015, 00:00 AM by Michael Croft
    Xconomy | Under a collaboration announced today, San Diego-based Cypher Genomics said it would use its biomarker discovery service to help New Jersey's Celgene identify key genetic variants among patients who respond well to specific drugs.
    Full story
  • Robert Gentleman on His Goals for Drug Discovery at 23andMe

    May 19, 2015, 11:00 AM by Michael Croft
    Bio-IT World | Robert Gentleman’s goal is to “bring bioinformatics and computational drug discovery to complement the really strong genetics” already at 23andMe. He spoke with Bio-IT World about open science at a for-profit venture, the challenges of drug discovery, and what’s left to find via SNP chips.
    Full story
  • Bluebird Regulators Map Out Approval Plan For Gene Therapy

    May 19, 2015, 00:00 AM by Michael Croft
    Xconomy | One of gene therapy's major unanswered questions is just what it'll take to convince U.S. regulators to approve one of these treatments.
    Full story
  • AWS upgrades highlight growing focus on cloud management

    May 19, 2015, 00:00 AM by Michael Croft
    Computerworld | Amazon Web Services is hoping better management tools will convince enterprises to move more applications to the cloud, but getting their internal management processes right is even more important than anything the vendor can offer.
    Full story
  • Kapa Biosystems Launches New RNA Prep Kit to Maximize Sequencing Efficiency

    May 18, 2015, 00:00 AM by Michael Croft
    WILMINGON, MA, UNITED STATES - May 18, 2015 - Kapa Biosystems, Inc., today launched a new RNA library preparation product for next-generation sequencing (NGS) workflows that enables users to generate a more complete view of the transcriptome by detecting more low-abundance and unique transcripts
    Full story
  • Can We Identify Every Kind of Cell in the Body

    May 18, 2015, 00:00 AM by Michael Croft
    MIT Technology Review | With new tools to isolate individual cells and profile their genetic signatures, researchers are undertaking a microscopic quest to find out what we're really made of.
    Full story
  • Latest Report - Enterprise ICT investment plans-ICT budget and staffing trends in Pharmaceuticals

    May 18, 2015, 00:00 AM by Michael Croft
    SAN FRANCISCO, CA, UNITED STATES - May 18, 2015 - Product Synopsis
     
    This report presents the findings from a survey of 102 pharmaceutical companies regarding their Information and Communications Technology (ICT) budgets and staff allocation
    Full story
  • Unlocking the Value of Smart Data & Analytics at Smart Data Summit Dubai Next Week

    May 18, 2015, 00:00 AM by Michael Croft
    DUBAI, UNITED ARAB EMIRATES - May 18, 2015 - The 2nd Annual Smart Data Summit will take place next week on 25-26 May at Sofitel Dubai The Palm Resort and Spa, Dubai, UAE
    Full story
  • Michael J. Fox Foundation Brings Parkinson's Data to tranSMART

    May 15, 2015, 10:15 AM by Michael Croft
    Bio-IT World | The Michael J. Fox Foundation, dedicated to driving basic research in Parkinson's disease, received a special Judges' Prize at this year's Bio-IT World Best Practices Awards for its work implementing the tranSMART platform for data sharing and analysis, including innovative programs like a patient registry and integration with studies of other neurodegenerative diseases.
    Full story
  • Oxford Nanopore Announces Auto Sample Prep, New Chips, Pay-As-You-Go Pricing

    May 14, 2015, 14:00 PM by Michael Croft
    Bio-IT World | Clive Brown’s Oxford Nanopore took over our Twitter feed on Thursday afternoon with news coming out of the London Calling event (#nanoporeconf). Many in attendance (and watching the Twitter feed) called the announcements “game-changing” and likened the atmosphere to Apple’s iPhone announcement in 2007. 
    Full story
  • Mayo Clinic Embarks on Population-Scale Pharmacogenomics Study

    May 14, 2015, 10:00 AM by Michael Croft
    Bio-IT World News Brief | Mayo Clinic in Rochester, Minn., has announced plans to sequence genes from 10,000 patients for genetic variants that could affect their responses to a variety of medications, as part of a study that will track the long-term health outcomes of patients who undergo pharmacogenetic testing.
    Full story